Live feed08:00:00·3mPRReleasevia QuantisnowLB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP CongressByQuantisnow·Wall Street's wire, on your screen.LBRX· LB Pharmaceuticals IncHealth Care
